kabutan

TRANSGENIC GROUP INC.(2342) Summary

2342
TSE Growth
TRANSGENIC GROUP INC.
294
JPY
+3
(+1.03%)
Jan 29, 3:30 pm JST
1.92
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
122.5
PBR
1.02
Yield
ー%
Margin Trading Ratio
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
289 JPY 1.88 USD
Previous Close Jan 28
291 JPY 1.90 USD
High Jan 29, 1:00 pm
301 JPY 1.96 USD
Low Jan 29, 9:02 am
287 JPY 1.87 USD
Volume
204,300
Trading Value
0.06B JPY 0.39M USD
VWAP
294.3 JPY 1.92 USD
Minimum Trading Value
29,400 JPY 192 USD
Market Cap
5.00B JPY 0.03B USD
Number of Trades
310
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Slightly High
1-Year Average
628
1-Year High Dec 4, 2025
20,104
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 0 1,579,100
Jan 16, 2026 0 1,667,800
Jan 9, 2026 0 1,660,000
Dec 26, 2025 9,000 1,434,100 159.34
Dec 19, 2025 3,000 1,205,000 401.67
Company Profile
TRANSGENIC GROUP INC. is a biotech venture supporting drug discovery research. The company specializes in genetic analysis using mice and is expanding through succession-based M&A.
Sector
Services
TRANSGENIC GROUP INC. operates two main business segments: drug discovery support and investment/consulting. In the drug discovery support segment, the company offers services such as genetically modified mouse production, antibody production, glycan analysis and synthesis, preclinical trials, and clinical trial outsourcing. The investment and consulting segment focuses on promoting new businesses through M&A and supporting business succession and revitalization. This segment includes various activities such as the sale of electrical products, import and sale of Western tableware, development and sale of information and communication equipment, import and sale of auxiliary materials for multi-layered glass and glass processing equipment, and import and sale of printer toners.